Price bobs and weaves on drug prices

President-elect Donald Trump’s nominee for HHS secretary, Rep. Tom Price (R-Ga.), dodged questions Wednesday about negotiation of drug price controls. Trump recently called for HHS to negotiate Medicare drug prices, a policy that Price has opposed in the past (see BioCentury, Jan. 16).

At a hearing of the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee, Sen. Bernie Sanders (I-Vt.) asked Price if he and Trump would support legislation to give HHS power to negotiate drug prices. Price responded that the “issue of drug pricing and drug costs is one of great concern,” but would not commit to supporting negotiation...